ARTICLE | Company News
FDA halts review of Ranbaxy applications
February 26, 2009 2:21 AM UTC
FDA halted review of all pending drug applications from Ranbaxy (NSE:RANBAXY; BSE:500359) containing data from the company's Paonta Sahib plant in India. The agency said Ranbaxy falsified data and tes...